In type 2 diabetes, SGLT2 inhibitors reduced risk for serious hyperkalemia without increasing hypokalemia

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{118be3d919724043adb52c8b3fb0edf4,

title = "In type 2 diabetes, SGLT2 inhibitors reduced risk for serious hyperkalemia without increasing hypokalemia",

author = "Kharisa Rachmasari and Montori, {Victor M.}",

year = "2022",

month = sep,

doi = "10.7326/J22-0063",

language = "English (US)",

volume = "175",

pages = "JC104",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "9",

}

TY - JOUR

T1 - In type 2 diabetes, SGLT2 inhibitors reduced risk for serious hyperkalemia without increasing hypokalemia

AU - Rachmasari, Kharisa

AU - Montori, Victor M.

PY - 2022/9

Y1 - 2022/9

UR - http://www.scopus.com/inward/record.url?scp=85138459365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85138459365&partnerID=8YFLogxK

U2 - 10.7326/J22-0063

DO - 10.7326/J22-0063

M3 - Comment/debate

C2 - 36063558

AN - SCOPUS:85138459365

SN - 0003-4819

VL - 175

SP - JC104

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 9

ER -